Complete Remission of Cavin-4 Immunoglobulin G Rippling Muscle Disease After Rituximab Therapy

JAMA Neurology · Published 2026-06-01 · DOI 10.1001/jamaneurol.2026.1519

Authors (3)

Tony Zhang, William J. Litchy, Divyanshu Dubey

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Zhang, T., Litchy, W., Dubey, D. (2026). Complete Remission of Cavin-4 Immunoglobulin G Rippling Muscle Disease After Rituximab Therapy. JAMA Neurology. https://doi.org/10.1001/jamaneurol.2026.1519

Related articles

• Neurological Manifestations in Adult Survivors of Ebola Virus Disease · JAMA Neurology · 2026 · Same journal
• Musical Trick Alleviating Benign Essential Blepharospasm · JAMA Neurology · 2026 · Same journal
• Comorbidities and Outcomes in People With Functional Neurological Disorder · JAMA Neurology · 2026 · Same journal
• Neurological Teleconsultations in General Practice · JAMA Neurology · 2026 · Same journal
• Serum Glial Fibrillary Acidic Protein Dynamics, Disease Progression, and Therapy Response in Multiple Sclerosis · JAMA Neurology · 2026 · Same journal
• Pathology and Genetics in a Global Cohort of Parkinsonian Disorders · JAMA Neurology · 2026 · Same journal
• Neurological Manifestations of Hantavirus Infection · JAMA Neurology · 2026 · Same journal
• Plasma eMTBR-tau243 and %p-tau217 for Biological Staging of Alzheimer Disease · JAMA Neurology · 2026 · Same journal
• Automated Speech Analysis to Identify Clinical, Anatomical, and Pathological Variants of Primary Progressive Aphasia · JAMA Neurology · 2026 · Same journal
• Moving Beyond Legal Phobia to Medicolegal Advocacy in Neurology · JAMA Neurology · 2026 · Same journal